Summit Financial LLC Has $575,000 Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Posted by Trevor Kearing on Apr 3rd, 2025

Summit Financial LLC lowered its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 3.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 6,382 shares of the exchange traded fund’s stock after selling 248 shares during the period. Summit Financial LLC’s holdings in SPDR S&P Biotech ETF were worth $575,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of XBI. Kohmann Bosshard Financial Services LLC bought a new position in SPDR S&P Biotech ETF during the 4th quarter valued at $29,000. Golden State Wealth Management LLC bought a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $29,000. Avior Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after purchasing an additional 307 shares during the last quarter. Lee Danner & Bass Inc. bought a new stake in SPDR S&P Biotech ETF in the 4th quarter worth about $38,000. Finally, Bank of Jackson Hole Trust purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at about $43,000.

SPDR S&P Biotech ETF Stock Up 3.1 %

Shares of NYSEARCA XBI opened at $80.59 on Thursday. The company has a market capitalization of $5.08 billion, a PE ratio of 11.47 and a beta of 1.00. The stock’s 50 day moving average price is $88.81 and its 200-day moving average price is $93.53. SPDR S&P Biotech ETF has a twelve month low of $77.26 and a twelve month high of $105.47.

SPDR S&P Biotech ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Wednesday, March 26th. Shareholders of record on Monday, March 24th were paid a $0.0053 dividend. The ex-dividend date was Monday, March 24th.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.